In addition, in a study on the different metabolic characteristics of breast cancer due to different metastatic sites, glutamine metabolic enzymes, including GDH, were significantly increased in breast cancer bone and liver metastases, whereas the glycolytic phenotype was mainly increased in brain and lung metastases. This evidence concerns the gene GLUD1 and breast carcinoma.